{"news_desk": "National", "print_page": "13", "subsection_name": null, "section_name": "Health", "byline": {"original": "By CATHERINE SAINT LOUIS", "person": [{"middlename": "Saint", "firstname": "Catherine", "role": "reported", "lastname": "LOUIS", "rank": 1, "organization": ""}]}, "abstract": "Drug Enforcement Agency refuses to reclassify marijuana from Schedule 1 drug to Schedule 2 drug, move that would remove it from list of nation's most dangerous drugs and ease research and medical use; decision angers scientists, public officials and advocates, although DEA says it will allow universities and private companies to apply to grow marijuana for research.", "type_of_material": "News", "word_count": "910", "keywords": [{"rank": "1", "value": "Medical Marijuana", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Marijuana", "is_major": "Y", "name": "subject"}, {"rank": "3", "value": "Drug Abuse and Traffic", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "United States Politics and Government", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "Drug Enforcement Administration", "is_major": "Y", "name": "organizations"}, {"rank": "6", "value": "Research", "is_major": "N", "name": "subject"}, {"rank": "7", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}], "lead_paragraph": "The agency decided not to reclassify marijuana from a Schedule 1 drug to a Schedule 2 drug, but removed a roadblock to medical studies of marijuana.", "pub_date": "2016-08-12T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "The agency decided not to reclassify marijuana from a Schedule 1 drug to a Schedule 2 drug, but removed a roadblock to medical studies of marijuana....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/08/12/health/dea-keeps-marijuana-on-list-of-dangerous-drugs-frustrating-advocates.html", "slideshow_credits": null, "blog": [], "_id": "57ad251b95d0e021d79803dd", "headline": {"main": "D.E.A. Keeps Marijuana on List of Dangerous Drugs, Frustrating Advocates", "print_headline": "D.E.A. Refusal to Reclassify Marijuana Draws Criticism"}}